SCHEMBL6877901

SCHEMBL6877901

CN1CCN(c2ccc(S(=O)(=O)O)cc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT6 Q8N6T7 2/20 0.56
ALDH1A1 P00352 3/20 0.55
KMT2A Q03164 2/20 0.55
GFER P55789 2/20 0.55
KDM4E B2RXH2 1/20 0.55
GAA P10253 1/20 0.55
MAPT P10636 1/20 0.55
ADRA2C P18825 1/20 0.55
PTK2B Q14289 1/20 0.55
ESR2 Q92731 1/20 0.55
LMNA P02545 2/20 0.51
NPC1 O15118 1/20 0.51
TP53 P04637 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
MEN1 O00255 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28170767 0.85 AKR1C3 (0.58) SIRT6ALDH1A1KMT2AGFERKDM4E
SCHEMBL5722125 0.83 ALDH1A1 (0.64) SIRT6ALDH1A1KMT2AGFERKDM4E
SCHEMBL3122573 0.82 LMNA (0.61) ALDH1A1KMT2AGFERKDM4EGAA
Hydrochloric Acid SCHEMBL27788243 0.80 LMNA (0.59) ALDH1A1KMT2AGFERKDM4EGAA
SCHEMBL1794248 0.80 HTR2C (0.51) SIRT6ALDH1A1KMT2AGAAMAPT
SCHEMBL17899709 0.79 KMT2A (0.50) SIRT6ALDH1A1KMT2AGFERKDM4E
SCHEMBL31531621 0.77 ALDH1A1 (0.71) SIRT6ALDH1A1KDM4ELMNATP53
Hydrochloric Acid SCHEMBL27788123 0.77 PKM (0.64) ALDH1A1KMT2AKDM4EMAPTLMNA
Hydrochloric Acid SCHEMBL7652831 0.76 LMNA (0.54) ALDH1A1KMT2AGFERKDM4EGAA
SCHEMBL6878147 0.76 RORC (0.49) ALDH1A1KMT2AKDM4EGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432417-A2 SUBSTITUTED BENZIMIDAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCER Aventis Pharma S.A. (FR) 2004-06-30 EP disclosed
WO-2003028721-A2 SUBSTITUTED BENZIMIDAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCER AVENTIS PHARMA S.A. (FR) 2003-04-10 WO disclosed